Jennifer King
Consultant / Advisor chez Ally Bridge Group HK Ltd
Profil
Jennifer King is currently working as an Advisor at Ally Bridge Group HK Ltd since 2022.
She previously worked as a Senior Director-Business Development at Shire Plc and as a Senior Vice President-Business Development at Intellia Therapeutics, Inc. She also served as an Independent Non-Executive Director at Exopharm Ltd.
from 2021 to 2023.
Dr. King holds an undergraduate degree from Massachusetts Institute of Technology, an MBA from Northeastern University, and a doctorate from Stanford University School of Medicine.
Postes actifs de Jennifer King
| Sociétés | Poste | Début |
|---|---|---|
Ally Bridge Group HK Ltd
 Ally Bridge Group HK Ltd Investment ManagersFinance Ally Bridge Group HK Ltd (Ally Bridge) is a private equity firm founded in 2011 by Frank Yu. The firm is headquartered in Hong Kong with additional office in the US. | Consultant / Advisor | 01/01/2022 |
Anciens postes connus de Jennifer King
| Sociétés | Poste | Fin |
|---|---|---|
| EXOPHARM | Director/Board Member | 22/02/2023 |
| SHIRE | Corporate Officer/Principal | - |
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Jennifer King
| Massachusetts Institute of Technology | Undergraduate Degree |
| Northeastern University | Masters Business Admin |
| Stanford University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| EXOPHARM | Health Technology |
| Entreprise privées | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Ally Bridge Group HK Ltd
Ally Bridge Group HK Ltd Investment ManagersFinance Ally Bridge Group HK Ltd (Ally Bridge) is a private equity firm founded in 2011 by Frank Yu. The firm is headquartered in Hong Kong with additional office in the US. | Finance |
